Advertisement

Research Article Free access | 10.1172/JCI116148

Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant.

J A Waters, M Kennedy, P Voet, P Hauser, J Petre, W Carman, and H C Thomas

Department of Medicine, St. Mary's Hospital Medical School, Imperial College of Science and Technology, London University, United Kingdom.

Find articles by Waters, J. in: JCI | PubMed | Google Scholar

Department of Medicine, St. Mary's Hospital Medical School, Imperial College of Science and Technology, London University, United Kingdom.

Find articles by Kennedy, M. in: JCI | PubMed | Google Scholar

Department of Medicine, St. Mary's Hospital Medical School, Imperial College of Science and Technology, London University, United Kingdom.

Find articles by Voet, P. in: JCI | PubMed | Google Scholar

Department of Medicine, St. Mary's Hospital Medical School, Imperial College of Science and Technology, London University, United Kingdom.

Find articles by Hauser, P. in: JCI | PubMed | Google Scholar

Department of Medicine, St. Mary's Hospital Medical School, Imperial College of Science and Technology, London University, United Kingdom.

Find articles by Petre, J. in: JCI | PubMed | Google Scholar

Department of Medicine, St. Mary's Hospital Medical School, Imperial College of Science and Technology, London University, United Kingdom.

Find articles by Carman, W. in: JCI | PubMed | Google Scholar

Department of Medicine, St. Mary's Hospital Medical School, Imperial College of Science and Technology, London University, United Kingdom.

Find articles by Thomas, H. in: JCI | PubMed | Google Scholar

First published December 1, 1992 - More info

Published in Volume 90, Issue 6 (December 1, 1992)
J Clin Invest. 1992;90(6):2543–2547. doi:10.1172/JCI116148.
Copyright © 1992, The American Society for Clinical Investigation.

Published December 1, 1992 Accepted: date unavailable
Abstract

A previous study (Carman, W. F., A. R. Zanetti, P. Karayiannis, J. A. Waters, G. Manzillo, E. Tanzi, A. J. Zuckerman, and H. C. Thomas. 1990. Lancet. 336:325-329) demonstrated a variant hepatitis B surface antigen (HBsAg) in a vaccinated child born to a hepatitis B virus-infected mother. A substitution of arginine for glycine at amino acid 145 in HBsAg was observed. In this study the effect of this substitution on the common "a" determinant of this protein, against which protective immunity is directed, is investigated. Using recombinant HBsAg with and without the amino acid substitution, the binding of monoclonal antibodies that recognize different epitopes of the "a" determinant, was shown to be destroyed by the presence of arginine at amino acid 145. In convalescent and vaccinee sera, antibody binding to HBsAg was not inhibited by the variant HBsAg. Immunization with the variant HBsAg, although eliciting a high titer antibody that recognized the variant, produced a low titer of antibody recognizing the native protein. Studies in mice demonstrate that the immunogenicity of the variant protein is also substantially altered. The data presented here demonstrate that this variant evades the known protective anti-HBs response and lends support to the suggestion that this mutation arose as the result of immune pressure.

Browse pages

Click on an image below to see the page. View PDF of the complete article

Version history
  • Version 1 (December 1, 1992): No description
Advertisement
Advertisement